Free Trial

NeoGenomics (NEO) Competitors

NeoGenomics logo
$7.41 +0.10 (+1.37%)
Closing price 07/1/2025 04:00 PM Eastern
Extended Trading
$7.60 +0.19 (+2.56%)
As of 08:49 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NEO vs. TNET, CARG, CNXC, DLO, PAGS, ATHM, ALIT, CLVT, WNS, and FA

Should you be buying NeoGenomics stock or one of its competitors? The main competitors of NeoGenomics include TriNet Group (TNET), CarGurus (CARG), Concentrix (CNXC), DLocal (DLO), PagSeguro Digital (PAGS), Autohome (ATHM), Alight (ALIT), Clarivate (CLVT), WNS (WNS), and First Advantage (FA). These companies are all part of the "business services" industry.

NeoGenomics vs. Its Competitors

NeoGenomics (NASDAQ:NEO) and TriNet Group (NYSE:TNET) are both business services companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

TriNet Group has a net margin of 3.32% compared to NeoGenomics' net margin of -11.54%. TriNet Group's return on equity of 237.87% beat NeoGenomics' return on equity.

Company Net Margins Return on Equity Return on Assets
NeoGenomics-11.54% -2.21% -1.22%
TriNet Group 3.32%237.87%5.60%

98.5% of NeoGenomics shares are owned by institutional investors. Comparatively, 96.8% of TriNet Group shares are owned by institutional investors. 2.4% of NeoGenomics shares are owned by company insiders. Comparatively, 37.1% of TriNet Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, NeoGenomics had 6 more articles in the media than TriNet Group. MarketBeat recorded 6 mentions for NeoGenomics and 0 mentions for TriNet Group. TriNet Group's average media sentiment score of 1.67 beat NeoGenomics' score of 0.42 indicating that TriNet Group is being referred to more favorably in the news media.

Company Overall Sentiment
NeoGenomics Neutral
TriNet Group Very Positive

NeoGenomics has a beta of 1.63, meaning that its stock price is 63% more volatile than the S&P 500. Comparatively, TriNet Group has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500.

NeoGenomics presently has a consensus target price of $13.83, suggesting a potential upside of 86.68%. TriNet Group has a consensus target price of $96.67, suggesting a potential upside of 28.82%. Given NeoGenomics' stronger consensus rating and higher possible upside, research analysts clearly believe NeoGenomics is more favorable than TriNet Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeoGenomics
0 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.45
TriNet Group
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

TriNet Group has higher revenue and earnings than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than TriNet Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeoGenomics$660.57M1.44-$78.73M-$0.61-12.15
TriNet Group$5.05B0.72$173M$3.3522.40

Summary

TriNet Group beats NeoGenomics on 9 of the 16 factors compared between the two stocks.

Get NeoGenomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NEO vs. The Competition

MetricNeoGenomicsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$940.76M$2.85B$5.48B$8.94B
Dividend YieldN/A2.69%5.38%4.12%
P/E Ratio-12.1521.1726.2119.74
Price / Sales1.44262.85395.51109.12
Price / Cash16.6641.8936.4957.06
Price / Book1.057.237.915.37
Net Income-$78.73M-$55.05M$3.15B$248.34M
7 Day Performance3.20%-0.60%0.77%1.67%
1 Month Performance3.35%3.77%3.46%4.56%
1 Year Performance-46.03%2.20%34.61%18.42%

NeoGenomics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NEO
NeoGenomics
4.0308 of 5 stars
$7.41
+1.4%
$13.83
+86.7%
-46.8%$940.76M$660.57M-12.152,200
TNET
TriNet Group
4.3505 of 5 stars
$73.25
+0.8%
$96.67
+32.0%
-24.3%$3.55B$5.05B21.873,600Positive News
CARG
CarGurus
4.2364 of 5 stars
$33.47
+0.6%
$36.95
+10.4%
+35.1%$3.49B$903.75M95.631,282
CNXC
Concentrix
4.6698 of 5 stars
$52.85
+2.2%
$66.75
+26.3%
-11.8%$3.38B$9.62B14.52450,000Earnings Report
Dividend Announcement
Analyst Forecast
Gap Up
DLO
DLocal
2.7075 of 5 stars
$11.34
-1.2%
$12.45
+9.8%
+36.5%$3.24B$745.97M23.141,095
PAGS
PagSeguro Digital
3.5119 of 5 stars
$9.64
+2.7%
$11.63
+20.6%
-17.7%$3.18B$18.84B7.908,595
ATHM
Autohome
3.2567 of 5 stars
$25.84
-0.3%
$32.00
+23.8%
-2.8%$3.10B$6.88B14.284,415
ALIT
Alight
4.319 of 5 stars
$5.67
+1.8%
$9.86
+73.8%
-18.4%$3.05B$2.33B-40.509,500
CLVT
Clarivate
1.6487 of 5 stars
$4.32
+0.2%
$5.00
+15.7%
-18.7%$2.95B$2.56B-4.4512,000
WNS
WNS
1.3241 of 5 stars
$63.41
+4.9%
$62.25
-1.8%
+21.0%$2.94B$1.31B17.0564,505High Trading Volume
FA
First Advantage
2.3448 of 5 stars
$16.61
+5.1%
$66.00
+297.4%
+7.8%$2.88B$1.05B553.675,500

Related Companies and Tools


This page (NASDAQ:NEO) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners